|
|
|
|
|
|
Atyr Pharma Inc (LIFE)
|
|
3.40 0 (+0.00%)
|
7/20/2017 3:59pm
|
|
Open:
|
3.35
|
Pre. Close:
|
3.40
|
|
High:
|
3.50
|
Low:
|
3.30
|
|
Volume:
|
52,917
|
Market Cap:
|
80.94M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
3.65 - 3.68
|
3.68 - 3.74
|
|
Low:
|
3.11 - 3.13
|
3.13 - 3.15
|
|
Close:
|
3.31 - 3.41
|
3.41 - 3.59
|
|
|
|
|
|
|
Technical analysis (as of: 2017-07-20 4:38:59 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 4.10 One year: 4.38
|
|
Support:
|
Support1: 3.12 Support2: 2.59
|
|
Resistance:
|
Resistance1:
3.51 Resistance2: 3.75
|
|
Pivot:
|
3.38 
|
|
Moving Averages:
|
MA(5): 3.34  MA(20): 3.45
MA(100): 3.40 MA(250): 3.18
|
|
MACD:
|
MACD(12,26):
-0.03 Signal(12,26,9): -0.02
|
|
%K %D:
|
%K(14,3): 39.44 %D(3): 34.61
|
|
RSI:
|
RSI(14): 49.52
|
|
52-Week:
|
High: 4.45
Low: 2.10 Change(%): 14.9
|
|
Average Vol(K):
|
3-Month: 2507
10-Days 1773
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.LIFE has closed below upper band by 47.3%. Bollinger Bands are 0.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Thu, 16 Mar 2017 20:08:24 GMT
aTyr Pharma Announces Fourth Quarter and Year-End 2016 Operating Results
Wed, 21 Sep 2016 21:01:59 GMT
aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J ...
Wed, 30 Mar 2016 20:03:07 GMT
aTyr Pharma Announces Encouraging Phase 1b/2 Results for Resolaris™ in its ...
Wed, 06 Jan 2016 21:04:45 GMT
aTyr Pharma Appoints Sanuj Ravindran, MD, as Chief Business Officer
Fri, 09 Dec 2016 14:14:00 GMT
aTyr Pharma to Present at the BMO Prescriptions for Success Healthcare Conference
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
